04/30/2026
An insightful article exploring the macroeconomic pressures shaping healthcare in 2026 — including declining insurance reimbursements, rising operational costs, and coverage challenges.
The piece highlights how these shifts are driving clinicians toward cash-pay and hybrid models, with regenerative treatments such as microfat playing an increasingly important role in building predictable and sustainable practice revenue.
Read more: https://stemwave.com/blog/2026-cash-pay-medicine
Article credit: Wave
Get up to date on the data behind why 2026 could turn out to be the year for cash-based therapies in your office.